Download PDF
CC BY 4.0 · Indian J Med Paediatr Oncol 2023; 44(05): 464-473
DOI: 10.1055/s-0043-1764369
Review Article

Role of Morphology in the Diagnosis of Acute Leukemias: Systematic Review

Mithraa Devi Sekar
1   Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
,
Manasa Raj
1   Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
,
Prabhu Manivannan 
1   Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
› Author Affiliations Funding None.
› Further Information
Also available at
   Permissions and Reprints

Abstract

The role of hematopathologists in the diagnosis of acute leukemia (AL) starts with the morphological examination of either peripheral blood smear or bone marrow. The morphological hallmark for the myeloblast includes “Auer rods” and “Phi bodies.” The addition of cytochemical stains such as myeloperoxidase, Sudan Black B, periodic acid-Schiff stain, nonspecific esterase, and Perls' stain acts as an important adjunct to the morphological classification in the resource-constrained settings. The recent World Health Organization classification still endorses the utility of morphology which requires the presence of either ≥ 20% lymphoblasts or myeloblasts/or its equivalents (monoblasts, promonocytes, or megakaryoblasts) and integrates it with the clinical features, immunophenotyping (IP), and molecular genetics for making the diagnosis of AL. Morphology can give clue to the specific diagnosis of acute myeloid leukemia (AML) with t(8:21), t(15:17), t(16:16), or inv(16) and this diagnosis can be made irrespective of blasts count if such translocations are demonstrated by molecular tests. There are some interesting findings such as blasts with “hand-mirror” morphology, nuclear cleavage, prominent cytoplasmic vacuoles, pseudo-Chediak-Higashi granules, cup-like nucleus, and other dysplastic features helping in differentiating lymphoid and myeloid leukemias. Transient abnormal myelopoiesis in Down syndrome and hypoplastic AL can be picked up on morphological examination. Bone marrow biopsy would be greatly beneficial and complementary to aspirate smears and is required for diagnosing exact cellularity, topography of cells, dyspoiesis, myelonecrosis, gelatinous marrow transformation, myelofibrosis, and IP can be performed using immunohistochemistry. Morphological examination in AL is not only helpful for diagnosis but also useful for predicting the prognosis in posttherapy cases, AML with myelodysplasia-related changes, therapy-related myeloid neoplasms, and mixed phenotype AL. Hematogones, blastoid mantle cell lymphoma, high grade B cell lymphoid with blastoid morphology, Burkitt leukemia, prolymphocytes in prolymphocytic leukemia, hairy cell leukemia variant, plasmablasts especially in plasmablastic leukemia, or plasma cell leukemia can mimic AL and IP is useful in these situations. Hence, morphology should be considered as a kind of “gold-standard” starting point for the analysis of AL cases. Morphological examination cannot be replaced and advanced tests cannot be used as surrogate for morphology.

Keywords

acute leukemia - lymphoblasts - myeloblasts - cytochemistry - blast equivalents - bone marrow biopsy - acute leukemia mimics


Publication History

Article published online:
17 April 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Kansal R. Toward integrated genomic diagnosis in routine diagnostic pathology by the World Health Organization classification of acute myeloid leukemia. J Clin Haematol. 2020; 1: 33-53
    Google Scholar
  • 2 Piller G. Leukaemia - a brief historical review from ancient times to 1950. Br J Haematol 2001; 112 (02) 282-292
    CrossrefPubMedGoogle Scholar
  • 3 Ladines-Castro W, Barragán-Ibañez G, Luna-Pérez MA. et al. Morphology of leukaemias. Rev Med Hosp Gen (Mex) 2016; 79: 107-113
    Google Scholar
  • 4 Bennett JM, Catovsky D, Daniel MT. et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976; 33 (04) 451-458
    CrossrefPubMedGoogle Scholar
  • 5 Bennett JM, Catovsky D, Daniel MT. et al. The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. Br J Haematol 1981; 47 (04) 553-561
    CrossrefPubMedGoogle Scholar
  • 6 Bennett JM, Catovsky D, Daniel MT. et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103 (04) 620-625
    CrossrefPubMedGoogle Scholar
  • 7 Bennett JM, Catovsky D, Daniel MT. et al; French-American-British (FAB) Cooperative Group. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. J Clin Pathol 1989; 42 (06) 567-584
    CrossrefPubMedGoogle Scholar
  • 8 Jaffe ES, Harris NL, Stein H, Vardiman JW. eds. Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues (World Health Organization Classification of Tumours). Lyon, France: IARC Press; 2001
  • 9 Kansal R. Classification of acute myeloid leukemia by the revised fourth edition World Health Organization criteria: a retrospective single-institution study with appraisal of the new entities of acute myeloid leukemia with gene mutations in NPM1 and biallelic CEBPA. Hum Pathol 2019; 90: 80-96
    CrossrefPubMedGoogle Scholar
  • 10 International Agency for Research on Cancer World Health Organization. . WHO Classification of Tumors. Accessed May 29, 2020, at: http://whobluebooks.iarc.fr/about/history.php
  • 11 Alaggio R, Amador C, Anagnostopoulos I. et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 2022:1–29
  • 12 Lewis SM, Bain BJ, Bates I. eds. Dacie and Lewis. Practical Haematology. Preparation and Staining Methods for Blood and Bone Marrow Smears. Vol. 4. China: Elsevier; 2006:57–68
  • 13 Singh T. . Atlas and Text of Hematology. New Delhi: Avichal Publishing Company; 2010:136
  • 14 Morilla R, Morilla AM, Nadal-Melsió E. . Immunophenotyping by flow cytometry. In: Bain BJ, Bates I, Laffan MA, eds. Dacie and Lewis. Practical Hematology. China: Elsevier; 2017:330–348
  • 15 Bain BJ, Clark DM, Wilkins BS. eds. Bone Marrow Pathology. Wiley-Blackwell, London: John Wiley & Sons; 2019
  • 16 Bates I, Bain BJ. eds. Approach to the Diagnosis and Classification of Blood Diseases. Dacie and Lewis Practical Haematology. China: Elsevier; 2012:549
  • 17 Swerdlow SH, Campo E, Harris NL. eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2017
  • 18 Löffler H, Gassmann W. Morphology and cytochemistry of acute lymphoblastic leukaemia. Baillieres Clin Haematol 1994; 7 (02) 263-272
    CrossrefPubMedGoogle Scholar
  • 19 Brunning RD, Orazi A, Porwit A. et al. Acute myeloid leukaemia, NOS. In: Swerdlow SH, Campo E, Harris NL, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. Lyon, France: IARC Press; 2017:156–166
  • 20 Arber DA, Brunning RD, Le Beau MM. et al. Acute myeloid leukaemia with recurrent genetic abnormalities. In: Swerdlow SH, Campo E, Harris NL, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. Lyon, France: IARC Press; 2017:130–145
  • 21 Bain BJ, Béné MC. Morphological and immunophenotypic clues to the WHO categories of acute myeloid leukaemia. Acta Haematol 2019; 141 (04) 232-244
    CrossrefPubMedGoogle Scholar
  • 22 Neame PB, Soamboonsrup P, Leber B. et al. Morphology of acute promyelocytic leukemia with cytogenetic or molecular evidence for the diagnosis: characterization of additional microgranular variants. Am J Hematol 1997; 56 (03) 131-142
    CrossrefPubMedGoogle Scholar
  • 23 Tricot G, Broeckaert-Van Orshoven A, Van Hoof A, Verwilghen RL. Sudan Black B positivity in acute lymphoblastic leukaemia. Br J Haematol 1982; 51 (04) 615-621
    CrossrefPubMedGoogle Scholar
  • 24 Stass SA, Pui CH, Melvin S. et al. Sudan black B positive acute lymphoblastic leukaemia. Br J Haematol 1984; 57 (03) 413-421
    CrossrefPubMedGoogle Scholar
  • 25 Borowitz MJ, Chan JKC, Bene M, Arber DA. . Precursor lymphoid neoplasms. T-lymphoblastic leukaemia/ lymphoma. In: Swerdlow SH, Campo E, Harris NL, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. Lyon, France: IARC Press; 2017:209–212
  • 26 Löffler H, Kayser W, Schmitz N. et al. Morphological and cytochemical classification of adult acute leukemias in two multicenter studies in the Federal Republic of Germany. Haematol Blood Transfus 1987; 30: 21-27
    PubMedGoogle Scholar
  • 27 Catovsky D, Bernasconi C, Verdonck PJ. et al. The association of eosinophilia with lymphoblastic leukaemia or lymphoma: a study of seven patients. Br J Haematol 1980; 45 (04) 523-534
    CrossrefPubMedGoogle Scholar
  • 28 Park BG, Chi HS, Jang S. et al. Association of cup-like nuclei in blasts with FLT3 and NPM1 mutations in acute myeloid leukemia. Ann Hematol 2013; 92 (04) 451-457
    CrossrefPubMedGoogle Scholar
  • 29 Bain BJ, Heller M, Toma S, Pavlů J. The cytological features of NPM1-mutated acute myeloid leukemia. Am J Hematol 2015; 90 (06) 560
    CrossrefPubMedGoogle Scholar
  • 30 Carluccio P, Mestice A, Pastore D. et al. Immunophenotypic and molecular features of ‘cuplike’ acute myeloid leukemias. Eur J Haematol 2014; 92 (02) 121-126
    CrossrefPubMedGoogle Scholar
  • 31 Mannelli F, Ponziani V, Bencini S. et al. CEBPA-double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features. Haematologica 2017; 102 (03) 529-540
    CrossrefPubMedGoogle Scholar
  • 32 Gill PS, Meyer PR, Pavlova Z, Levine AM. B cell acute lymphocytic leukemia in adults. Clinical, morphologic, and immunologic findings. J Clin Oncol 1986; 4 (05) 737-743
    CrossrefPubMedGoogle Scholar
  • 33 Arber DA, Brunning RD, Orazi A. et al. Acute myeloid leukaemia with myelodysplasia-related changes. In: Swerdlow SH, Campo E, Harris NL, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. Lyon, France: IARC Press; 2017:150–152
  • 34 Vardiman JW, Arber DA, Brunning RD. et al. Therapy-related myeloid neoplasms. In: Swerdlow SH, Campo E, Harris NL, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. Lyon, France: IARC Press; 2017:153–155
  • 35 Giagounidis AA, Hildebrandt B, Heinsch M, Germing U, Aivado M, Aul C. Acute basophilic leukemia. Eur J Haematol 2001; 67 (02) 72-76
    CrossrefPubMedGoogle Scholar
  • 36 Borowitz MJ, Bene M, Harris NL, Porwit A, Matutes E, Arber DA. . Acute leukaemias of ambiguous lineage. In: Swerdlow SH, Campo E, Harris NL, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. Lyon, France: IARC Press; 2017:180–187
  • 37 Bene MC, Castoldi G, Knapp W. et al; European Group for the Immunological Characterization of Leukemias (EGIL). Proposals for the immunological classification of acute leukemias. Leukemia 1995; 9 (10) 1783-1786
    PubMedGoogle Scholar
  • 38 Arber DA, Baumann I, Niemeyer CM, Brunning RD, Porwit A. . Myeloid proliferations associated with Down syndrome. In: Swerdlow SH, Campo E, Harris NL, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. Lyon, France: IARC Press; 2017:169–171
  • 39 Pileri SA, Orazi A, Falini B. . Myeloid sarcoma. In: Swerdlow SH, Campo E, Harris NL, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. Lyon, France: IARC Press; 2017:167–168
  • 40 Cazzola M, Malcovati L, Invernizzi R. Myelodysplastic/myeloproliferative neoplasms. Hematology (Am Soc Hematol Educ Program) 2011; 2011: 264-272
    CrossrefPubMedGoogle Scholar
  • 41 Chirnomas SD, Kupfer GM. The inherited bone marrow failure syndromes. Pediatr Clin North Am 2013; 60 (06) 1291-1310
    CrossrefPubMedGoogle Scholar
  • 42 Kalaivani S, Saranya GD, Kar R, Basu D. Role of immunohistochemistry in acute leukemias with myelonecrosis. Indian J Hematol Blood Transfus 2018; 34 (04) 643-647
    CrossrefPubMedGoogle Scholar
  • 43 Rekha JS, Kar R, Basu D. Myelonecrosis: a clinicopathological study from a tertiary care center in South India over a twelve-year period. Bone Marrow Res 2014; 2014: 890510
    CrossrefPubMedGoogle Scholar
  • 44 Saad AA. . “Juvenile Myelomonocytic Leukemia (JMML): A Mimicker of KMT2A-Rearranged Acute Myeloid Leukemia (AML).” Acute Leukemias. London: Intech Open; 2020